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Abstract: 
Objective: The aim of this study was to 
measure the incidence, treatment and outcome of 
non-traumatic Subarachnoid Haemorrhage (SAH) 
cases occurring in Malta during the five-year period 
between January 2011 and December 2015, in order 
to determine whether the lack of a local 
neurovascular service is associated with a poor 
outcome. 
Method: A retrospective analysis of adult 
patients (above the age of 16) diagnosed with non-
traumatic SAH was carried out. The data collected 
included a five-year period from January 1st 2011 
till December 31st 2015.  
Results: The incidence of SAH was estimated 
at 4.04 cases per 100,000 population per year. An 
underlying aneurysm was found to be the cause of 
the SAH in 69.1 % of cases investigated with CT 
angiography or Cerebral Angiography. In these 
patients, definitive management in the form of 
coiling or clipping of the aneurysm was carried out, 
within the period between January 1st 2011 and 
December 31st 2015, in the United Kingdom as part 
of an agreement between the two countries. The 
outcome of these patients measured at 6 months 
using the Modified Rankin Scale (MRS) was found 
to be excellent. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion: Despite our geographical and 
logistical limitations, outcomes of those patients 
with initial low Hunt and Hess (H+H) scores have 
not been affected by the lack of a local 
neurovascular service. Results are comparable to 
those of other international centres. Further studies 
looking into feasibility of expanding our local 
services are being carried out.  
 
Keywords 
Subarachnoid haemorrhage, aneurysm, 
incidence, Modified Rankin Scale 
 
Abbreviations: 
- Subarachnoid Haemorrhage (SAH)  
- Computerized Tomography (CT) 
- Computerized Tomography Angiography 
(CTA) 
- Magnetic Resonance Angiogram (MRA) 
- Modified Rankin Scale (MRS) 
- Hunt and Hess (H+H)  
- Arterio-venous malformation (AVM) 
- United Kingdom (UK) 
- Mater Dei Hospital (MDH).  
- Anterior communicating artery (ACA) 
- Glasgow Coma Scale (GCS) 
- Intensive Treatment Unit (ITU) 
- Lower Urinary Tract Infection (LUTI) 
- External Ventricular Drain (EVD ) 
- Cerebrospinal Fluid (CSF ) 
- Medical Out-patients (MOP) 
 
Introduction 
Subarachnoid Haemorrhage (SAH) refers to 
the extravasation of blood into the subarachnoid 
space between the pial and arachnoid membranes 
causing a haemorrhagic stroke.1 It has an overall 
global incidence of 9/100,000 per year.2 It may 
occur in a wide variety of clinical contexts 
including head trauma. Non-traumatic or 
spontaneous SAH is most commonly caused by a 
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ruptured cerebral aneurysm and to a lesser extent 
due to arterio-venous malformation (AVM).  
Mortality due to SAH has been shown to be 
significant at 50% with 10-15% dying prior to 
arrival at hospital.3 
In January 2017, the population of Malta was 
reported as 420,869.4 Currently, there is only one 
study which describes the incidence and outcomes 
of non-traumatic SAH cases in the Maltese 
population. This was carried out over the 2-year 
period 2009-2010.5 The purpose of our study is to 
re-evaluate the incidence and outcome of non-
traumatic SAH during the five-year period between 
January 2011 and December 2015. The study was 
also aimed at determining whether the lack of a 
local neurovascular service, and hence the transport 
of patients to the UK for definitive treatment, is 
associated with a poor outcome. 
 
Study Methods 
All patients in the Maltese Islands who 
present with symptoms suggestive of a SAH are 
managed at the main public hospital, Mater Dei 
Hospital (MDH). They are admitted under the care 
of one of our four Consultant Neurologists. Patients 
who are seen at private clinics are quickly 
transferred to the general hospital MDH for further 
investigation and treatment since there are no other 
facilities on the island equipped to treat this 
condition.  
Data of adult patients (≥ 16 years of age), with 
a clinical diagnosis of SAH from January 1st 2011 
till December 31st 2015, was collected and analysed 
from 4 separate sources:  
1. Patients who were referred abroad for 
treatment of ruptured aneurysms were 
obtained from the Treatment Abroad 
Committee; 
2. Patients whose cause of death on the death 
certificate was listed as “Subarachnoid 
Haemorrhage” from the Death Register; 
3. Patients who were discharged from Mater Dei 
Hospital with a diagnosis of SAH were 
identified from the hospital activity analysis, 
using ICD9 coding system; 
4. Patients who were diagnosed with SAH on CT 
Brain were collected using the hospital 
computer system RIS Centricity Web. 
 
All patients who were diagnosed with a 
traumatic SAH were excluded.  
The patients who died out of hospital were 
identified solely from the Death Register. All other 
patients were identified from more than one of the 
above mentioned sources, therefore ensuring that 
the data collection was thorough and complete.  
This method guaranteed that there were no missed 
SAH cases that were admitted to hospital.  
 
Results 
The total number of patients with definitive 
spontaneous non-traumatic SAH over the five-year 
period was 85. Therefore, the incidence rate of SAH 
in the Maltese population is calculated to be 4.04 
per 100,000 population per year. There was a 
significant increase from the previous study which 
calculated the incidence to be 3.16 per 100,000 
population per year.   
 
a) Patient characteristics 
Of the 85 patients admitted with non-
traumatic SAH over the study period, 49 (58%) 
were female and 36 (42%) were male. The mean 
age of presentation was 55 (range between ages 17 
to 89).  One patient died before arrival to hospital 
and before receiving medical attention. This patient 
was certified dead due to SAH according to their 
death certificate confirmed by post-mortem 
examination. The death of this patient was not 
analyzed further since the death happened outside 
of hospital and there were no available medical 
notes. 
 
b) Clinical presentation 
Almost all patients presented with sudden 
onset, severe, thunderclap headache, usually 
associated with photophobia, nausea and vomiting. 
21 patients presented with loss of consciousness, 9 
presented to hospital in an unresponsive state and 3 
presented with confusion. One patient presented 
with a generalized tonic-clonic seizure, whilst 
another 5 patients presented with cardiac arrest 
needing resuscitation. Other commonly described 
symptoms included dizziness, neck pain, 
inappropriate/slurred speech and visual disturbances 
such as blurred or double vision. Tables 1 and 
Figure 1 seen below demonstrate the H+H Scores 
on admission.  
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Table 1: Hunt and Hess Scores on admission 
 
Hunt and Hess Score Percentage for total of 84 patients 
1 1.2% 
2 54.8% 
3 16.7% 
4 26.2% 
5 1.2% 
 
 
 
Figure 1: Hunt and Hess Scores on admission - percentage for total of 84 patients
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
c) Risk factor profile 
The main risk factors described in our cohort 
of patients were: hypertension in 14 patients, 
smoking in 19 patients, hyperlipidemia in 4 patients 
and diabetes mellitus in another 4 patients. Other 
pre-existing conditions included: 1 patient with 
Systemic Lupus Erythematosus, 1 patient with 
Chronic Lymphocytic Leukaemia, 1 patient with 
glucose-6-phosphatase deficiency and 1 patient who 
was diagnosed with Hepatitis C.  
 
d) Investigations 
All patients, excluding the patient who died 
out-of-hospital, had a non-contrast CT scan of the 
brain. SAH was confirmed in all patients on CT 
scan except for two patients. One of these presented 
7 days after onset of severe headache. This patient 
had an unremarkable CT scan, however a 
subsequent MRI of the brain confirmed a SAH and 
a right-sided anterior communicating artery (ACA) 
aneurysm. The other patient whose CT scan was 
reported as normal presented with an occipital 
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Total study cohort (n=85)
CT diagnosis of non-traumatic SAH (n=84)
No further imaging (n=15) CT/MRA performed (n=69)
CT angio -ve (n=20) CT angio +ve (n=49)
Transferred to UK (n=40)
Not transferred to UK (n=9)
Death in transit to hospital (n=1)
thunderclap headache radiating to the frontal area. 
A follow-up CT angiogram reported the presence of 
basilar artery spasm.  
A lumbar puncture was only carried out on 
one patient and xanthochromia was confirmed with 
an opening pressure of 35 mmH20, confirming the 
diagnosis of SAH.  
Following a diagnosis of SAH on CT of the 
brain, 15 patients with a low Glasgow Coma Scale 
(GCS) and multiple co-morbidities were deemed 
unfit for angiography. They were not investigated 
with further imaging modalities and were treated 
conservatively. Of these, 14 patients passed away 
within the first few days of admission. The 
remaining patient had a 6-month post-diagnosis 
MRS score of 5 and was being managed at the 
rehabilitation hospital. 
The other 69 patients were investigated for the 
possibility of underlying aneurysm with further 
imaging modalities including CT cerebral 
angiogram (CTA) or magnetic resonance 
angiography (MRA). 49 of them were found to 
have one or more aneurysm (71% of all those 
patients who received angiography). 40 of these 
patients were referred to the United Kingdom (UK) 
for definitive treatment of the aneurysm and 9 were 
not. Of these 9 patients who remained at MDH, 8 
patients passed away during the admission and 1 
survived to the 6-month follow-up visit. The 20 
patients who were investigated with further imaging 
modalities but did not have any cerebral 
arteriovenous malformations or cerebral aneurysms 
detected were managed symptomatically at MDH. 
This is summarised in Figure 2 and detailed in 
Table 2 below. 
 
 
 
Figure 2: Summary of investigation and patient flow between 2011 and 2015. 
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Table 2: Details of investigation and patient flow in each of the 5 years of the study. 
 2011 2012 2013 2014 2015 Total 
CT diagnosis of non-traumatic SAH 16 15 19 15 19 84 
No further imaging 7 0 4 3 1 15 
CT angio -ve 4 6 4 2 4 20 
CT angio +ve and transferred 5 8 9 8 10 40 
CT angio +ve and not transferred 0 1 2 2 4 9 
 
 
Table 3: List of post-op complications reported in 16 patients treated abroad 
 
Patient Complications 
1 
Frontal lobe ischemia rendering him aphasic, global weakness 3/5, 
apathetic; LUTI E.Coli 
2 Cerebral salt wasting syndrome 
3 
Staphylococcal sepsis; fluctuating symptoms of aggression and visual 
hallucinations; severe postural hypotension 
4 Cataracts; right eye ptosis 
5 Vasospasm; drop in GCS 
6 Seizures 
7 Puncture site hematoma/pseudoaneurysm 
8 UTI 
9 Intracerebral bleeding;  Bilateral ischemic infarcts 
10 Frontotemporal stroke; Right hemiparesis 
11 Neurogenic pulmonary oedema; Nosocomial chest infection 
12 Vasospasm 
13 Long QTc intervals on ECG 
14 Re-bleed from aneurysm 
15 
Ventriculitis with coagulase-negative streptococcus, followed by CSF 
leak from his EVD site 
16 
Hydrocephalus, extreme agitation; multisystemic pathology including 
Klebsiella Pneumoniae chest infection. 
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Table 4: Modified Rankin Scale (MRS) 
 
 MRS  
 0 1 2 3 4 5 6 Lost to f/u Total 
Number of patients with no 
angiography 
0 0 0 0 0 1 13 1 15 
Number of patients 
transferred to UK 
17 8 1 1 1 2 1 9 40 
Number of patients with +ve 
CTA but not transferred 
0 0 0 0 1 0 8 0 9 
Number of patients with -ve 
CTA and not transferred 
16 2 0 0 0 0 2 0 20 
Total 33 10 1 1 2 3 24 10 84 
 
 
 
e) Management 
Most patients were admitted to Neuro-
Medical Ward, however the patients with a low 
GCS on admission were managed directly in 
Intensive Care. Upon diagnosis of SAH, treatment 
with Nimodipine, lactulose and analgesia was 
immediately initiated.  
 
f) Length of Stay 
Of the 39 patients that were transferred to the 
UK for further treatment, 31 of them had an average 
stay in Malta of 2.84 days before being flown 
abroad. 5 patients required an extended stay at ITU 
in view of initial low GCS, averaging 26 days. 2 
patients had missing information in their medical 
file and 1 patient was flown to his home country 
with no further input regarding management. 
The average stay of 27 patients that received 
treatment abroad was that of 19 days. This has to 
take into consideration their post-op care and any 
complications that arose. 11 patients did not have 
the official discharge letter in their medical file, 
hindering us from obtaining official dates and any 
procedures done. One patient spent 10 days in 
hospital; however, no treatment was eventually 
given.  
 
g) Outcome of SAH 
Patients in general had a good long-term 
outcome from their coiling or clipping procedure. 
However, a number of complications were reported 
post-op, as indicated in Table 3.  
 
h) Complications occurring in patients with SAH 
who did not undergo coiling or clipping 
One patient who was managed conservatively 
suffered a small area of infarction left frontal 
region, including severe headaches (repeat CT 
Brain showed no hydrocephalus but resolution of 
SAH) and high blood pressure. 
 
i) Post-treatment follow-up 
Patients were advised to have repeat imaging 
between 4 to 6 months after the procedure in Malta. 
This ranged from CT scans, an MRA or a cerebral 
angiogram, depending on the patient’s case. Every 
patient was followed up at MOP to assess for any 
residual symptoms and to ensure that the 
aneurysm/AVM was successfully treated with no 
evidence of a recurrence of bleeding.   
Two patients who were referred to the UK for 
definitive treatment were not of Maltese nationality. 
They did not return to Malta after transfer abroad 
and were lost to follow-up. The remaining patients 
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who underwent coiling or clipping and returned 
from the UK, were followed up at Neurology 
Outpatients for at least 6 months.  
 
j) Mortality 
Out of the total of 85 patients diagnosed with 
non-traumatic SAH, 25 patients passed away during 
the admission at MDH or at the rehabilitation 
hospital before the 6-month follow-up. (29% 
mortality). All deaths occurred within an average of 
5.41 days. Out of the total 40 patients who were 
transferred to the UK for definitive treatment, 39 of 
them survived past the 6 month follow-up. The 
remaining patient who was transferred, passed away 
after 30 days in the UK post-coiling. Eight out of 
nine patients who were diagnosed with an aneurysm 
on CTA and not transferred abroad succumbed to 
their illness. The 6-month mortality of patients 
transferred to the UK was therefore 2% while that 
of the patients who were not transferred was 88.9%. 
The majority of the deaths occurred in patients with 
a H+H score of >3 on admission and in patients 
who were deemed unfit to undergo further 
investigations during the admission and not stable 
enough for transfer abroad.   
It must be noted that two of the patients who 
were transferred for treatment abroad were lost to 
follow–up since they returned to their respective 
home countries after definitive treatment. 
This left 7 patients from the transferred abroad 
group who were lost to follow-up or did not attend 
the 6 month post treatment review.  
Table 4 shows the Modified Rankin Score at 6 
months after the initial presentation for the patients 
who were followed-up. 
 
Discussion 
All patients diagnosed with a SAH are 
ultimately referred and managed at MDH, the main 
acute hospital in Malta and the only hospital 
offering the services of a critical care unit. In our 
study, the data was compiled in such a way so as to 
represent all cases of non-traumatic SAH which 
occurred in Malta during the study period chosen. 
The incidence of 4.04 per 100,000 population per 
year is on the lower side of average incidence data 
however it has shown a rise when compared to the 
previous incidence of 3.16 per 100,000 population 
measured during the period between 2009-2010.  
The worldwide incidence of non traumatic SAH has 
been shown to be about 10.5 per 100,000 person 
years. 10    
Patient who are diagnosed with a ruptured 
aneurysmal SAH, should ideally receive definitive 
treatment as early as possible. Every effort is made 
from our end in order to minimize delays in transfer 
of patients abroad, however certain logistical 
limitations may be inevitable; such as when the 
patient remains unfit for air transfer and requires 
stabilization. Our audit shows that the mean number 
of days from initial presentation to definitive 
treatment in the UK was 2.84 days. 
The average hospital volume estimated from 
our results adds up to a value of 17 cases per year. 
The association between outcomes for patients with 
SAH and hospital treatment volume has been 
described in multiple studies.6-8 It has been shown 
that hospitals which treat more cases of SAH, have 
substantially lower rates of in-hospital mortalities, 
when compared to low-volume hospitals.6 Better 
outcomes at high-volume hospitals may be 
attributed to the specialized services and staff 
expertise. The definition of high-volume hospitals 
described in the literature varies.  It ranges from 
cut-points between 5 cases per year7 and up to 45 
cases per year.8 For ruptured aneurysms, it has been 
shown that an institution using coil embolization 
would be expected to have fewer in-patient deaths 
when compared to an institution which never used 
this technique.8 
Selection bias giving rise to confounding 
factors occurs since certain high-risk and unstable 
patients with ruptured aneurysms are not considered 
for coil embolization and physicians are reluctant to 
transfer such cases with a poor prognosis.8 
The literature shows that patients who are 
acutely ill with high Hunt and Hess grades after 
SAH can however undergo successful coil 
embolization despite their poor medical condition 
and a high frequency of vasospasm. In one series, 
27 patients with 29 aneurysms were all H+H grade 
4 or 5 (poor grade) and were treated within 72 hours 
after ictus. Sixteen patients (59%) died within 30 
days of SAH, whereas 11 (41%) survived. Eight 
patients (30%) had a favorable outcome (MRS ≤2). 
Therefore, these results were similar to what was 
seen in aggressively treated surgical patients. Many 
of these patients have a good clinical outcome, 
although there still remain high rates of morbidity 
and mortality with this disease.9 Such a 
consideration would therefore justify ongoing 
efforts at introducing a neurovascular service 
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locally. 
The main limitation of this audit is the small 
population size, giving our study a low power. 
 
Conclusion 
Our study has shown that the incidence of 
non-traumatic SAH in Malta remains on the low-
incidence range, when compared to other countries. 
CTA and MRA were successful in diagnosing at 
least one aneurysm in each of the 71% patients with 
a positive CT brain. Despite the low incidence and 
the logistical limitations for delivering patients to 
centres in the UK for definitive treatment of 
aneurysmal bleeds, our standard of care and 
survival rates are not below those of other centres. 
The 6-month mortality of patients transferred to the 
UK was 2% while that of the patients who were not 
transferred was 88.9%. 
However current efforts at introducing a 
specialised neurovascular service locally could still 
result in the added benefits of avoiding logistical 
problems in transfer of patients, reducing costs, and 
in the possibility of treatment of the high-risk 
patients who would otherwise not receive definitive 
coiling of the aneurysm. Further studies would then 
be required in order to assess such a service and the 
outcome of both the low- and high-risk patients 
with non-traumatic SAH receiving treatment.  
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